United States securities and exchange commission logo





             December 13, 2022

       Benjamin Sexson
       Chief Executive Officer
       Monogram Orthopaedics Inc.
       3913 Todd Lane
       Austin, TX 78744

                                                        Re: Monogram
Orthopaedics Inc.
                                                            Offering Statement
on Form 1-A
                                                            Filed November 29,
2022
                                                            File No. 024-12084

       Dear Benjamin Sexson:

            We have conducted a limited review of your offering statement and
do not have any
       comments.

               We will consider qualifying your offering statement at your
request. If a participant in
       your offering is required to clear its compensation arrangements with
FINRA, please have
       FINRA advise us that it has no objections to the compensation
arrangements prior to
       qualification.

               We remind you that the company and its management are
responsible for the accuracy
       and adequacy of their disclosures, notwithstanding any review, comments,
action or absence of
       action by the staff. We also remind you that, following qualification of
your Form 1-A, Rule 257
       of Regulation A requires you to file periodic and current reports,
including a Form 1-K which
       will be due within 120 calendar days after the end of the fiscal year
covered by the report.

             Please contact Conlon Danberg at 202-551-4466 or Margaret Schwartz
at 202-551-
       7153 with any questions.




             Sincerely,


             Division of Corporation Finance

             Office of Industrial Applications and

             Services
       cc:                                              Andrew Stephenson, Esq.